Fifth Third Bancorp lowered its stake in Teleflex Incorporated (NYSE:TFX – Free Report) by 11.8% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 38,898 shares of the medical technology company’s stock after selling 5,198 shares during the quarter. Fifth Third Bancorp’s holdings in Teleflex were worth $4,864,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Maryland State Retirement & Pension System grew its holdings in Teleflex by 40.5% during the third quarter. Maryland State Retirement & Pension System now owns 12,095 shares of the medical technology company’s stock valued at $1,512,000 after purchasing an additional 3,486 shares during the period. Illinois Municipal Retirement Fund grew its stake in Teleflex by 4.7% in the third quarter. Illinois Municipal Retirement Fund now owns 23,801 shares of the medical technology company’s stock valued at $2,976,000 after acquiring an additional 1,071 shares during the period. Keybank National Association OH acquired a new position in Teleflex in the third quarter valued at about $536,000. AlphaCore Capital LLC bought a new stake in shares of Teleflex in the third quarter worth about $358,000. Finally, Fulcrum Asset Management LLP bought a new stake in shares of Teleflex in the third quarter worth about $343,000. 95.62% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
TFX has been the topic of a number of research analyst reports. Mizuho set a $160.00 price objective on Teleflex in a report on Friday, November 6th. Truist Financial upped their target price on shares of Teleflex from $142.00 to $167.00 and gave the stock a “hold” rating in a research note on Monday, November 9th. Needham & Company LLC increased their target price on Teleflex from $159.00 to $170.00 and gave the stock a “buy” rating in a report on Tuesday, August 25th. Zacks Research downgraded Teleflex from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 23rd. Finally, UBS Group boosted their price target on Teleflex from $145.00 to $158.00 and gave the company a “neutral” rating in a report on Tuesday, August 11th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $163.30.
Get Our Latest Stock Analysis on Teleflex
Teleflex Stock Up 1.8%
Teleflex stock opened at $159.99 on Wednesday. The company has a market cap of $6.35 billion, a P/E ratio of 20.38, a price-to-earnings-growth ratio of 1.05 and a beta of 0.85. Teleflex Incorporated has a 1-year low of $100.18 and a 1-year high of $161.00. The company has a fifty day simple moving average of $134.43 and a 200 day simple moving average of $127.90. The company has a current ratio of 2.01, a quick ratio of 1.59 and a debt-to-equity ratio of 0.44.
Teleflex (NYSE:TFX – Get Free Report) last issued its quarterly earnings results on Thursday, November 5th. The medical technology company reported $2.63 EPS for the quarter, topping the consensus estimate of $1.90 by $0.73. Teleflex had a net margin of 13.51% and a return on equity of 10.57%. The firm had revenue of $567.80 million for the quarter, compared to analysts’ expectations of $565.52 million. During the same period in the previous year, the firm posted $3.67 EPS. The company’s revenue for the quarter was up .1% on a year-over-year basis. Research analysts anticipate that Teleflex Incorporated will post 7.67 earnings per share for the current fiscal year.
Teleflex Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Thursday, December 31st. Investors of record on Monday, November 16th will be given a dividend of $0.34 per share. The ex-dividend date of this dividend is Monday, November 16th. This represents a $1.36 annualized dividend and a yield of 0.9%. Teleflex’s dividend payout ratio is 16.52%.
Teleflex Company Profile
Teleflex is a global medical technology company that develops, manufactures and markets single-use medical devices used by healthcare professionals in hospitals and other care settings. Its products support a range of procedures, including vascular access, anesthesia, critical care, surgery, urology and emergency medicine. The company’s offerings include vascular and interventional access devices, catheters, airway management products, surgical instruments and other devices used in diagnostic and therapeutic procedures.
Further Reading
- Five stocks we like better than Teleflex
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
